Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Angenendt

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Proteomics|April 27, 2005
Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infectionsSigrid Steller, Philipp Angenendt, Dolores J Cahill, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqSJohannes Fredebohm, Daniel H Mehnert, Ann-Kathrin Löber, et al.
Analytical Chemistry|April 1, 2004
Cell-free protein expression and functional assay in nanowell chip formatPhilipp Angenendt, Lajos Nyarsik, Witold Szaflarski, et al.
Analytical Chemistry|May 18, 2004
Seeing better through a MIST: evaluation of monoclonal recombinant antibody fragments on microarraysPhilipp Angenendt, Jeannine Wilde, Gregor Kijanka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Detection of tumor DNA at the margins of colorectal cancer liver metastasisMatthias Holdhoff, Kerstin Schmidt, Frank Diehl, et al.
Science (New York, N.Y.)|August 8, 2009
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsJihye Yun, Carlo Rago, Ian Cheong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral bloodMichaela J Higgins, Danijela Jelovac, Evan Barnathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2016
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)Chris Karlovich, Jonathan W Goldman, Jong-Mu Sun, et al.
Oncotarget|May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Oncotarget|September 26, 2015
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Proteomics|April 27, 2005
Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infectionsSigrid Steller, Philipp Angenendt, Dolores J Cahill, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqSJohannes Fredebohm, Daniel H Mehnert, Ann-Kathrin Löber, et al.
Analytical Chemistry|April 1, 2004
Cell-free protein expression and functional assay in nanowell chip formatPhilipp Angenendt, Lajos Nyarsik, Witold Szaflarski, et al.
Analytical Chemistry|May 18, 2004
Seeing better through a MIST: evaluation of monoclonal recombinant antibody fragments on microarraysPhilipp Angenendt, Jeannine Wilde, Gregor Kijanka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Detection of tumor DNA at the margins of colorectal cancer liver metastasisMatthias Holdhoff, Kerstin Schmidt, Frank Diehl, et al.
Science (New York, N.Y.)|August 8, 2009
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsJihye Yun, Carlo Rago, Ian Cheong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral bloodMichaela J Higgins, Danijela Jelovac, Evan Barnathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2016
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)Chris Karlovich, Jonathan W Goldman, Jong-Mu Sun, et al.
Oncotarget|May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Oncotarget|September 26, 2015
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Pageof 3